文献速递心境障碍焦虑、强迫与应激相关障碍

抑郁症成人抗抑郁药与苯二氮䓬类同时起始使用及后续长期使用趋势

Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

同时新使用比例从2001年6.1%升至2012年12.5%,2014年稳定于11.3%。同时新使用者中12.3%长期使用苯二氮䓬类,且6个月抗抑郁治疗延续率与不同时使用者相似。

要点

  • 抑郁成人开始抗抑郁药时约十分之一同时新起始苯二氮䓬类,比例2001至2012年上升。
  • 同时新使用并未提高6个月抗抑郁治疗延续率。
  • 同时新使用者中12.3%长期使用苯二氮䓬类,需关注初始供应天数与长效药物等风险因素。

核心结论

  • 抑郁成人开始抗抑郁药时同时新起始苯二氮䓬类者占10.6%,且该比例2001至2012年上升。
  • 同时新使用与不同时新使用的6个月抗抑郁治疗长度相似,未见有意义的差异。
  • 同时新使用者中12.3%后续长期使用苯二氮䓬类,需谨慎考虑同时起始及苯二氮䓬类方案本身。

研究设计与样本

  • 美国商业保险索赔数据库队列研究,纳入2001年1月1日至2014年12月31日年龄18至64岁、近期诊断抑郁且开始抗抑郁药治疗、既往一年未使用抗抑郁药或苯二氮䓬类的成人。
  • 同时新使用定义为新苯二氮䓬类处方与新抗抑郁药处方在同一天配发。

主要发现

  • 同时起始使用比例从2001年6.1%(95% CI,5.5%-6.6%)升至2012年12.5%(95% CI,12.3%-12.7%),2014年稳定于11.3%(95% CI,11.1%-11.5%),2001至2014年年均增加0.49%(95% CI,0.47%-0.51%)。
  • 同时新使用者与非同时新使用者的抗抑郁治疗长度相似。
  • 同时新使用者中12.3%(95% CI,12.0%-12.5%)表现为长期苯二氮䓬类使用,64.0%在初始配药后停用苯二氮䓬类。
  • 同时新使用后长期苯二氮䓬类使用的决定因素包括初始苯二氮䓬类供应天数较长、首次处方为长效苯二氮䓬类、近期阿片类处方配药。

临床怎么用

  • 临床在抑郁患者起始抗抑郁药时,应审慎评估是否同时新起始苯二氮䓬类,因同时使用未显示改善6个月抗抑郁治疗延续。
  • 对同时新起始苯二氮䓬类的患者,应关注初始供应天数、长效药物选择及近期阿片类使用等长期使用风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Benzodiazepines have been prescribed for short periods to patients with depression who are beginning antidepressant therapy to improve depressive symptoms more quickly, mitigate concomitant anxiety, and improve antidepressant treatment continuation. However, benzodiazepine therapy is associated with risks, including dependency, which may take only a few weeks to develop. OBJECTIVES: To examine trends in simultaneous benzodiazepine and antidepressant new use among adults with depression initiating an antidepressant, assess antidepressant treatment length by simultaneous new use status, estimate subsequent long-term benzodiazepine use in those with simultaneous antidepressant and benzodiazepine new use, and identify determinants of simultaneous new use and long-term benzodiazepine use. DESIGN, SETTING, AND PARTICIPANTS: This cohort study using a US commercial claims database included commercially insured adults (aged 18-64 years) from January 1, 2001, through December 31, 2014, with a recent depression diagnosis who began antidepressant therapy but had not used antidepressants or benzodiazepines in the prior year. EXPOSURES: Simultaneous new use, defined as a new benzodiazepine prescription dispensed on the same day as a new antidepressant prescription. MAIN OUTCOMES AND MEASURES: The proportion of antidepressant initiators with simultaneous new use and continuing antidepressant treatment for 6 months and the proportion of simultaneous new users receiving long-term (6-months) benzodiazepine therapy. RESULTS: Of the 765 130 adults (median age, 39 years; interquartile range, 29-49 years; 507 451 women [66.3%]) who initiated antidepressant treatment, 81 020 (10.6%) also initiated benzodiazepine treatment. The mean annual increase in the proportion simultaneously starting use of both agents from 2001 to 2014 was 0.49% (95% CI, 0.47%-0.51%), increasing from 6.1% (95% CI, 5.5%-6.6%) in 2001 to 12.5% (95% CI, 12.3%-12.7%) in 2012 and stabilizing through 2014 (11.3%; 95% CI, 11.1%-11.5%). Similar findings were apparent by age group and physician type. Antidepressant treatment length was similar in simultaneous new users and non-simultaneous new users. Among simultaneous new users, 12.3% (95% CI, 12.0%-12.5%) exhibited long-term benzodiazepine use (64.0% discontinued taking benzodiazepines after the initial fill). Determinants of long-term benzodiazepine use after simultaneous new use were longer initial benzodiazepine days' supply, first prescription for a long-acting benzodiazepine, and recent prescription opioid fills. CONCLUSIONS AND RELEVANCE: One-tenth of antidepressant initiators with depression simultaneously initiated benzodiazepine therapy. No meaningful difference in antidepressant treatment at 6 months was observed by simultaneous new use status. Because of the risks associated with benzodiazepines, simultaneous new use at antidepressant initiation and the benzodiazepine regimen itself require careful consideration.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bushnell GA, Stürmer T, Gaynes BN, et al. Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014. JAMA Psychiatry. 2017. PMID: 28593281. doi:10.1001/jamapsychiatry.2017.1273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。